These are our medicines available in the Republic of Ireland. For the SPC and PIL information, please click on the medicine name:
- Alprolix® (eftrenonacog alfa)
- Altuvoct® ▼ (efanescotocog alfa)
- Aspaveli®(pegcetacoplan)
- Doptelet®(avatrombopag)
- Elocta® (efmoroctocog alfa)
- Kineret® (anakinra)
- Orfadin® capsules (nitisinone)
- Orfadin® oral suspension (nitisinone)
▼ This treatment is subject to additional monitoring.
Patient safety is a priority for Sobi. We are committed to collect, analyse and react upon any new information about the benefits and risks of our treatments. If you have information about a side effect or adverse reaction associated with any of our products, please use our online reporting form: Report a side effect
If you are unable to submit a side effect electronically, please use the local safety contact details available on the reporting page linked above.
You can also report side effects directly to Health Products Regulatory Authority (HPRA) via HPRA Pharmacovigilance, website: www.hpra.ie
For Product Complaints, please contact [email protected]
For Medical Information enquiries, please contact +44 (0)800 111 4754 or email [email protected]
Oct, 2026